Actively Recruiting
Pelvic Floor Muscle Training for Urinary Incontinence in Women with Myotonic Dystrophy Type 1: a Feasibility and Acceptability Study
Led by Université de Sherbrooke · Updated on 2025-02-24
12
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
U
Université de Sherbrooke
Lead Sponsor
C
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Collaborating Sponsor
AI-Summary
What this Trial Is About
Myotonic dystrophy type 1 (DM1) is a neuromuscular disorder that can affect multiple systems, including the urinary system through pelvic floor muscles (PFM). This study evaluates the feasibility and acceptability of pelvic floor muscle training to reduce urinary incontinence in women with DM1. The research aims to explore whether strengthening these muscles can improve symptoms and quality of life in this specific population, as this approach has not been previously studied in DM1 patients. Participants will undergo a 12-week pelvic floor muscle training program involving weekly 60-minute sessions with an experienced physiotherapist. These sessions include exercises with biofeedback, education, and a home exercise program. The study focuses on a single group of 12 women diagnosed with adult phenotype DM1 and experiencing urinary incontinence. Throughout the study, participants' adherence to treatment sessions and home exercises will be tracked. Assessments at baseline and after the 12-week program will measure urinary incontinence frequency, pelvic floor muscle function and size, urogynecological symptoms, quality of life impact, and participants' overall satisfaction and perceived improvement. The study also monitors recruitment, retention, and acceptability of the intervention, with follow-up evaluations two weeks post-treatment.
CONDITIONS
Brief Title
Pelvic Floor Muscle Training for Women with Myotonic Dystrophy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Confirmed medical diagnosis of myotonic dystrophy type 1 (DM1) with adult phenotype
- Symptoms of stress, urge, or mixed urinary incontinence
- Able to give free and informed consent
You will not qualify if you...
- Being pregnant, having given birth vaginally in the last year, or planning to become pregnant in the next six months
- Post-void residual urine volume greater than or equal to 150 ml
- Medical conditions that may affect urinary incontinence symptoms or treatment response
- Presence of fecal incontinence at least once per week or significant prolapse beyond the hymen
- Previous physiotherapy for pelvic floor rehabilitation or surgery on the perineum
- Having a defibrillator, pacemaker, or bladder stimulator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 weeks
Participants attend 12 weekly sessions of pelvic floor muscle training with an experienced physiotherapist, including exercises with biofeedback, home exercise teaching, and education.
12 weekly visits (in-person)
Duration - 2 weeks
Participants complete assessments after the 12-week treatment program to evaluate treatment effects and satisfaction.
1 post-treatment visit (in-person)
Trial Site Locations
Total: 1 location
1
Clinique des maladies neuromusculaires
Jonquière, Quebec, Canada, G7X 7X2
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here